Insider Transactions in Q3 2023 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Minnie Baylor Henry Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
59,200
-77.7%
|
-
|
|
Sep 21
2023
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
447,024
-90.02%
|
-
|
|
Sep 21
2023
|
Jeffrey Stein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68,625
-85.43%
|
-
|
|
Sep 21
2023
|
Kristine Peterson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,000
-87.34%
|
-
|
|
Sep 21
2023
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Sale (or disposition) back to the issuer
|
Direct |
415,209
-89.7%
|
-
|
|
Sep 21
2023
|
Rolf K Hoffmann Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
84,000
-88.1%
|
-
|
|
Sep 21
2023
|
Evan Loh CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,327,981
-90.26%
|
-
|
|
Sep 21
2023
|
Adam Woodrow President & Chief Commercial |
SELL
Sale (or disposition) back to the issuer
|
Direct |
749,034
-91.54%
|
-
|
|
Sep 21
2023
|
Timothy R Franson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
72,000
-86.11%
|
-
|
|
Sep 21
2023
|
Michael Bigham Exec. Chairman of the Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,358,032
-91.58%
|
-
|
|
Sep 21
2023
|
Robert S Radie Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
73,000
-86.3%
|
-
|
|
Sep 21
2023
|
Thomas John Dietz Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
69,250
-85.56%
|
-
|
|
Aug 09
2023
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
31,250
-2.29%
|
$62,500
$2.2 P/Share
|
|
Aug 09
2023
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
27,603
-6.23%
|
$55,206
$2.2 P/Share
|
|
Aug 09
2023
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
34,526
-7.17%
|
$69,052
$2.2 P/Share
|
|
Aug 09
2023
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
48,967
-3.56%
|
$97,934
$2.2 P/Share
|
|
Aug 08
2023
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
98,750
+11.63%
|
-
|
|
Aug 08
2023
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
156,250
+10.26%
|
-
|
|
Aug 08
2023
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+13.23%
|
-
|
|
Aug 08
2023
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
73,750
+13.28%
|
-
|
|
Aug 08
2023
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
168,750
+10.92%
|
-
|